Antares Pharma, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC MJC

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/16/2022

Shares

173,438

Value ($000)

711

Weight

0.0%

2013 Q4 - 2022 Q1 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/16/2022	711	0.0%	173,438	3/31/2022
2021 Q4	2/14/2022	611	0.0%	171,155	12/31/2021
2021 Q3	11/15/2021	610	0.0%	167,600	9/30/2021
2021 Q2	8/16/2021	723	0.0%	165,870	6/30/2021
2021 Q1	5/14/2021	678	0.0%	164,952	3/31/2021
2020 Q4	3/1/2021	623	0.0%	156,152	12/31/2020
2020 Q3	11/13/2020	422	0.0%	156,152	9/30/2020
2020 Q2	8/14/2020	429	0.0%	156,152	6/30/2020
2020 Q1	5/15/2020	405	0.0%	171,419	3/31/2020
2019 Q4	2/14/2020	758	0.0%	161,216	12/31/2019
2014 Q1	5/23/2014	3,947	0.0%	1,127,596	3/31/2014
2013 Q4	1/31/2014	3,916	0.0%	874,296	12/31/2013